Company intelligence / Profile preview

DreaMed Diabetes

Petah Tikva, Central District, Israeldreamed.ai ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

DreaMed Diabetes has developed FDA-cleared and CE-marked AI-powered platforms that provide personalized insulin dosing recommendations based on data from continuous glucose monitors, blood glucose meters, and insulin pumps. Clinical studies have shown improved time-in-range and A1C outcomes. The technology has been deployed in leading U.S. hospitals such as Yale New Haven Health System, Texas Children's Hospital, University of Florida, among others.

Therapeutic areas: Endocrinology
Modalities: DeviceSoftware as a Service (SaaS)Artificial intelligence-based therapy management tool
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

endo.digital

Commercial

Indications: Type 1 diabetes, Type 2 diabetes

Partnerships

Yale New Haven Health SystemTexas Children’s HospitalUniversity of Florida Pediatric Endocrinology ClinicGlooko digital platform integrationMedtronic licensing agreement for artificial pancreas algorithm used in MiniMed pumps.

Beyond the preview

Go deeper on DreaMed Diabetes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DreaMed Diabetes.

Explore the full profile